Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Astrasana
Zurich, Zurich, Switzerlandastrasana.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Astrasana is a Swiss-based medical cannabis company that operates as a vertically integrated group across Europe and Asia. The company focuses on the cultivation, production, and international distribution of high-quality medical cannabis products, including flowers, extracts, and oils. Astrasana provides pharmaceutical-grade cannabinoids to pharmacies, hospitals, and wholesalers, ensuring compliance with Good Manufacturing Practice (GMP) standards. With a strong presence in Switzerland and the Czech Republic, the company aims to bridge the gap between cannabis production and patient access to medical-grade treatments.
- Therapeutic areas
- PsychiatryNeurologyGastroenterology
- Modalities
- Small molecule
- Industry
- Biotech
Beyond the preview
Go deeper on Astrasana.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Astrasana.